Concepedia
Statistics
Publications
101
Citations
5.9K
H-Index
44
Active since
1982
Affiliations
Lund University(Current)
Active Biotech (Sweden)
Umeå University
University of Münster
Uppsala University
Tomas Leanderson is an author at Lund University specializing in life sciences, immunology, and inflammation.
Publications per year
1982–2018
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
Marina Karaghiosoff, Ralf Steinborn, Pavel Kovarik et al. · Nature Immunology · 2003 · 363 citations
Life Sciences, Immunology, Molecular Biology +14
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
Per Björk, Anders Björk, Thomas Vogl et al. · PLoS Biology · 2009 · 359 citations · Full text
Life Sciences, Immunology, Pharmacology +17
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
Giuseppe Mancuso, Angelina Midiri, Carmelo Biondo et al. · The Journal of Immunology · 2007 · 246 citations · Full text
Life Sciences, Immunology, Microbiology +17
Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation
Thomas Vogl, Athanasios Stratis, Viktor Wixler et al. · Journal of Clinical Investigation · 2018 · 230 citations · Full text
Life Sciences, Immunology, Molecular Biology +17
IFN-β Gene Deletion Leads to Augmented and Chronic Demyelinating Experimental Autoimmune Encephalomyelitis
Ingrid Teige, Alexandra Treschow, Anna Teige et al. · The Journal of Immunology · 2003 · 201 citations · Full text
Life Sciences, Immunology, Neuroscience +17
1–5 of 101